Retinal Pigment Epithelium is the Structure that Provides the Critical Blood-Retinal Barrier in Healthy Eyes and is the Structure that is Compromised in Retinitis Pigmentosa Type 11
VP-001 is the First and Only Treatment to Demonstrate Restoration of this Critical Barrier Function in a Patient-Derived Model
This Result Builds Further Confidence that VP-001 will have Meaningful Clinical Impact for Patients and Highlights the Competitive Advantages of PYC's RNA Approach over Other Genetic Medicine Approaches
PR Newswire
NEW YORK and PERTH, Australia, March 2, 2021
